PropertyValue
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1007/s13238-020-00803-w
?:journal
  • Protein_Cell
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/ac91b01a1338bb33de79c93dc27a0164f43841e5.json
?:pmcid
?:pmid
?:pmid
  • 33210243.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
?:type
?:year
  • 2020-11-18

Metadata

Anon_0  
expand all